Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Insulin-dependent diabetes linked to sharply higher dementia risk

Individuals with diabetes are at an increased risk of developing dementia but those with insulin-requiring type 2 diabetes and type 1 diabetes have the greatest risk, according to research presented at the 28th European Congress of Endocrinology in Prague.

8 May 2026

Extensive data analysis confirms the safety of aluminum adjuvanted vaccines

Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long-term health outcomes, including autism, diabetes, and asthma, finds a review of the latest data published by The BMJ today.

7 May 2026

AI-driven model predicts type 1 diabetes risk with greater accuracy

Researchers use machine learning and genetic analysis to uncover type 1 diabetes risk factors, improving prediction accuracy and identifying patient subtypes.

5 May 2026

T1GRS model enhances prediction of genetic risk for Type 1 diabetes

In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce energy.

30 Apr 2026

ISSCR urges NIH to continue support human embryonic stem cell research

The International Society for Stem Cell Research (ISSCR) has submitted a formal response to a Request for Information (RFI) issued by the National Institutes of Health (NIH) regarding its pause on new submissions to the NIH Human Embryonic Stem Cell (hESC) Registry and considerations to reduce reliance on hESCs in federally supported research.

25 Apr 2026

Type 1 diabetes preserves fitness but alters oxygen use in teens

The study highlights early microvascular impairment in adolescents with type 1 diabetes, emphasizing the importance of monitoring vascular health in this group.

24 Apr 2026

Real-time CGM transforms blood glucose management in type 2 diabetes

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults living with type 2 diabetes who are treated with basal insulin.

23 Apr 2026

Study identifies key risk factors driving MASLD across populations

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population.

23 Apr 2026

Why heart risk is hard to predict in type 1 diabetes

A European study reveals cardiovascular risk patterns in type 1 diabetes, highlighting the need for tailored prevention strategies to catch complications early.

20 Apr 2026

Dynamic AI models detect body tipping points to forecast disease before symptoms

The editorial, "Dynamics-driven medical big data mining: dynamic approaches to early disease forecasting and individualized care," published in Intelligent Medicine (February 2026, Volume 6, Issue 1), was written by Lu Wang (Tianjin Medical University), Han Lyu (Beijing Friendship Hospital, Capital Medical University), and Bin Sheng (Shanghai Jiao Tong University).

10 Apr 2026

Scientists find new genetic causes for diabetes in babies

Scientists have found new genetic causes for diabetes in babies – in a part of the genome that has historically been overlooked in genetic studies.

9 Apr 2026

Early genetic signals connect diabetes subgroups to heart disease risk

A growing body of research shows that diabetes can be stratified into five different subgroups. Researchers at Lund University have now investigated whether a person's genetic predisposition to different diabetes subgroups can help assess the risk of developing coronary artery disease.

7 Apr 2026

Diverse biobank study links genetics to disease risk and treatment

A new study by UCLA Health published in Cell presents a major advancement in the future of personalized medicine by pinpointing new connections between people's genes, disease risk and medicine response by using a clinically well-characterized and diverse population-represented biobank.

27 Mar 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated with lower risks of major cardiovascular events and end-stage kidney disease over five years. The study also found no increased risk of hospitalization for diabetic ketoacidosis or severe hypoglycemia, supporting further randomized trials of GLP-1RAs as adjunctive therapy in type 1 diabetes.

22 Mar 2026

Mandated caps reduce insulin out-of-pocket costs among US Medicare beneficiaries

A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined in insulin prices.

19 Mar 2026

People with type 1 diabetes face higher risk of developing dementia

Having type 1 diabetes is associated with a higher risk of developing dementia, according to a study published March 18, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

18 Mar 2026

Researchers show how smartwatches can help identify insulin resistance

Researchers developed a scalable framework that predicts insulin resistance using wearable-device signals, routine blood biomarkers, and demographic data, with stronger performance when these data streams were combined. The study also introduced an AI agent to explain insulin resistance risk, interpret results, and support earlier metabolic risk screening.

17 Mar 2026

Kyoto University unveils noninvasive assessment for diabetes

In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of the disease, so preserving or restoring beta cell mass is a central treatment goal.

13 Mar 2026

UCF researcher explores insulin signaling as new target for diabetic neuropathy

Neuropathy – chronic pain, numbness and tingling in the hands and feet – is a challenging fact of life for many patients with Type 1 diabetes.

2 Mar 2026

Forecasting disease intensity through genomic risk

Approximately 60,000 Danes live with chronic inflammatory bowel disease. Some experience limited discomfort, while others go through a debilitating disease course involving surgery and a stoma. Add to this the fear of leaving home due to urgent toilet needs.

2 Mar 2026